CX3CR1 and pulmonary arterial hypertension: Fractalkine (FKN) and its receptor CX3CR1 are critical mediators in thevascular and tissue damage of several chronic diseases, including systemicsclerosis (SSc) and pulmonary arterial hypertension (PAH).